EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) 21. September 2017, section EUDA news
23. April 2026 Coming soon: European Drug Report 2026 to be released on 9 June in Brussels New substances, new markets, new risks — understanding Europe’s changing drug landscape starts with solid facts. On 9 June,...
